Satsuma Pharmaceuticals Operating Income 2020-2023 | STSA
Satsuma Pharmaceuticals operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Satsuma Pharmaceuticals Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-71 |
| 2021 | $-51 |
| 2020 | $-48 |
| 2019 | $-29 |
| 2018 | $-8 |
| 2017 | $-5 |
| Satsuma Pharmaceuticals Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-03-31 | $-11 |
| 2022-12-31 | $-24 |
| 2022-09-30 | $-15 |
| 2022-06-30 | $-16 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-16 |
| 2021-09-30 | $-13 |
| 2021-06-30 | $-12 |
| 2021-03-31 | $-10 |
| 2020-12-31 | $-12 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-11 |
| 2019-09-30 | $-8 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-3 |
